Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Joseph Melenhorst

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Blood Reviews|September 17, 2024
Advancing CAR T-cell therapies: Preclinical insights and clinical translation for hematological malignanciesArun K Arunachalam, Céline Grégoire, Beatriz Coutinho de Oliveira, et al.
British Journal of Haematology|September 12, 2024
Chimeric antigen receptor T-cell therapy for haematological malignancies: Insights from fundamental and translational research to bedside practiceCéline Grégoire, Beatriz Coutinho de Oliveira, Paolo F Caimi, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 27, 2006
Robust expansion of viral antigen-specific CD4+ and CD8+ T cells for adoptive T cell therapy using gene-modified activated T cells as antigen presenting cellsJan Joseph Melenhorst, Scott Robert Solomon, Aarthi Shenoy, et al.
Haematologica|October 16, 2012
Donor lymphocyte count and thymic activity predict lymphocyte recovery and outcomes after matched-sibling hematopoietic stem cell transplantZachariah McIver, Jan Joseph Melenhorst, Colin Wu, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
MCL1 may not mediate chemoresistanceKylin A Emhoff, Kunho Chung, Dongmei Zhang, et al.
Frontiers in Immunology|May 23, 2022
PD1 Expression in EGFRvIII-Directed CAR T Cell Infusion Product for Glioblastoma Is Associated with Clinical ResponseOliver Y Tang, Lifeng Tian, Todd Yoder, et al.
Melanoma Research|January 29, 2026
Treatment effect of neoadjuvant immunotherapy in melanoma correlates with tumor burden: meta-analysis of reported clinical trialsDaniela Duarte-Bateman, Joseph M Escandón, Alan Shen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 30, 2018
Dominant-Negative TGF-β Receptor Enhances PSMA-Targeted Human CAR T Cell Proliferation And Augments Prostate Cancer EradicationChristopher C Kloss, Jihyun Lee, Aaron Zhang, et al.
Critical Care Explorations|December 10, 2020
Endothelial Biomarkers Are Associated With Indirect Lung Injury in Sepsis-Associated Pediatric Acute Respiratory Distress SyndromeJane E Whitney, Rui Feng, Natalka Koterba, et al.
Cancers|September 28, 2024
Advancing Cholangiocarcinoma Care: Insights and Innovations in T Cell TherapyNeda Dadgar, Arun K Arunachalam, Hanna Hong, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Blood Reviews|September 17, 2024
Advancing CAR T-cell therapies: Preclinical insights and clinical translation for hematological malignanciesArun K Arunachalam, Céline Grégoire, Beatriz Coutinho de Oliveira, et al.
British Journal of Haematology|September 12, 2024
Chimeric antigen receptor T-cell therapy for haematological malignancies: Insights from fundamental and translational research to bedside practiceCéline Grégoire, Beatriz Coutinho de Oliveira, Paolo F Caimi, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 27, 2006
Robust expansion of viral antigen-specific CD4+ and CD8+ T cells for adoptive T cell therapy using gene-modified activated T cells as antigen presenting cellsJan Joseph Melenhorst, Scott Robert Solomon, Aarthi Shenoy, et al.
Haematologica|October 16, 2012
Donor lymphocyte count and thymic activity predict lymphocyte recovery and outcomes after matched-sibling hematopoietic stem cell transplantZachariah McIver, Jan Joseph Melenhorst, Colin Wu, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
MCL1 may not mediate chemoresistanceKylin A Emhoff, Kunho Chung, Dongmei Zhang, et al.
Frontiers in Immunology|May 23, 2022
PD1 Expression in EGFRvIII-Directed CAR T Cell Infusion Product for Glioblastoma Is Associated with Clinical ResponseOliver Y Tang, Lifeng Tian, Todd Yoder, et al.
Melanoma Research|January 29, 2026
Treatment effect of neoadjuvant immunotherapy in melanoma correlates with tumor burden: meta-analysis of reported clinical trialsDaniela Duarte-Bateman, Joseph M Escandón, Alan Shen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 30, 2018
Dominant-Negative TGF-β Receptor Enhances PSMA-Targeted Human CAR T Cell Proliferation And Augments Prostate Cancer EradicationChristopher C Kloss, Jihyun Lee, Aaron Zhang, et al.
Critical Care Explorations|December 10, 2020
Endothelial Biomarkers Are Associated With Indirect Lung Injury in Sepsis-Associated Pediatric Acute Respiratory Distress SyndromeJane E Whitney, Rui Feng, Natalka Koterba, et al.
Cancers|September 28, 2024
Advancing Cholangiocarcinoma Care: Insights and Innovations in T Cell TherapyNeda Dadgar, Arun K Arunachalam, Hanna Hong, et al.
Pageof 4